TrialJapanese journal of clinical oncology2013

Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck.

Susumu Okano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.